On Monday, Cogent Biosciences Inc (NASDAQ: COGT) opened lower -3.98% from the last session, before settling in for the closing price of $4.77. Price fluctuations for COGT have ranged from $4.62 to $12.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -33.00%. Company’s average yearly earnings per share was noted 9.38% at the time writing. With a float of $95.39 million, this company’s outstanding shares have now reached $110.46 million.
Let’s determine the extent of company efficiency that accounts for 205 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cogent Biosciences Inc is 16.22%, while institutional ownership is 91.51%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.60% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Check out the current performance indicators for Cogent Biosciences Inc (COGT). In the past quarter, the stock posted a quick ratio of 5.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.47, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.87 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Looking closely at Cogent Biosciences Inc (NASDAQ: COGT), its last 5-days average volume was 1.94 million, which is a jump from its year-to-date volume of 1.42 million. As of the previous 9 days, the stock’s Stochastic %D was 6.30%. Additionally, its Average True Range was 0.49.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 4.78%, which indicates a significant decrease from 10.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.15% in the past 14 days, which was lower than the 63.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.52, while its 200-day Moving Average is $9.08. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $4.88. Second resistance stands at $5.17. The third major resistance level sits at $5.49. If the price goes on to break the first support level at $4.27, it is likely to go to the next support level at $3.95. Should the price break the second support level, the third support level stands at $3.66.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are currently 113,850K shares outstanding in the company with a market cap of 521.43 million. Presently, the company’s annual sales total 0 K according to its annual income of -255,860 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -67,930 K.
